All these evidences illustrate how mut-p53, by inducing ample structural modifications of the secretory trafficking machinery, can amplify the range and intensity of the tumor cell secretome, while also tuning the entire crosstalk of cancer cells with both surrounding and distant microenvironments. The gene discussed is TP53; the disease is neoplasm.